Info
Significant Ownership

Significant Ownership of Lind Global Fund III LP

Signature - Title: By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton - Jeff Easton, Managing Member
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Lind Global Fund III LP.

Notify me when Lind Global Fund III LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Lind Global Fund III LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
IVDA	Iveda Solutions, Inc.	Common Stock, par value $0.00001 per share	10%	$1,054,617		1,158,920		Lind Global Fund III LP	11 Feb 2026
ENVB	Enveric Biosciences, Inc.	Common Stock, $0.01 par value	10%	$552,346		141,265		Lind Global Fund III LP	28 Jan 2026
DFSC	DEFSEC Technologies Inc.	Common Shares, no par value	9.9%	$683,329		197,494		Lind Global Fund III LP	18 Dec 2025
BNGO	Bionano Genomics, Inc.	Common Stock, $0.0001 par value per share	9.4%	$1,669,500	+$851,703	1,050,000	+104%	Lind Global Fund III LP	31 Dec 2025
SLXN	Silexion Therapeutics Corp	Ordinary shares, par value $0.0135 per share	6.4%	$187,000	-$10,164	212,500	-5.2%	Lind Global Fund III LP	30 Sep 2025

Schedules 13D/G Reported by Lind Global Fund III LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.